Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Free Report)’s stock price fell 2.8% during mid-day trading on Tuesday . The company traded as low as $0.66 and last traded at $0.68. 65,906 shares changed hands during mid-day trading, a decline of 1% from the average session volume of 66,374 shares. The stock had previously closed at $0.70.
Shuttle Pharmaceuticals Price Performance
The stock’s fifty day moving average is $0.78.
Shuttle Pharmaceuticals Company Profile
Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .
Featured Articles
- Five stocks we like better than Shuttle Pharmaceuticals
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Profitably Trade Stocks at 52-Week Highs
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Shuttle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shuttle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
